180 related articles for article (PubMed ID: 22813631)
21. Examining the pathways linking lower socioeconomic status and advanced melanoma.
Pollitt RA; Swetter SM; Johnson TM; Patil P; Geller AC
Cancer; 2012 Aug; 118(16):4004-13. PubMed ID: 22179775
[TBL] [Abstract][Full Text] [Related]
22. A randomized trial to improve early detection and prevention practices among siblings of melanoma patients.
Geller AC; Emmons KM; Brooks DR; Powers C; Zhang Z; Koh HK; Heeren T; Sober AJ; Li F; Gilchrest BA
Cancer; 2006 Aug; 107(4):806-14. PubMed ID: 16832795
[TBL] [Abstract][Full Text] [Related]
23. Cutaneous melanoma and intervention strategies to reduce tumor-related mortality: what we know, what we don't know, and what we think we know that isn't so.
Rhodes AR
Dermatol Ther; 2006; 19(1):50-69. PubMed ID: 16405570
[TBL] [Abstract][Full Text] [Related]
24. Communication about family members' risk of melanoma: self-reported practices of dermatologists in the United States.
Oliveria SA; Heneghan MK; Halpern AC; Hay JL; Geller AC
Arch Dermatol; 2012 May; 148(5):621-7. PubMed ID: 22250188
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous melanoma: public health approach to early detection.
Weinstock MA
Dermatol Ther; 2006; 19(1):26-31. PubMed ID: 16405567
[TBL] [Abstract][Full Text] [Related]
26. [Melanoma in organ transplant patients].
Lévêque L; Dalac S; Dompmartin A; Louvet S; Euvrard S; Catteau B; Hazan M; Schollhamer M; Aubin F; Dreno B; Daguin P; Chevrant-Breton J; Frances C; Bismuth MJ; Tanter Y; Lambert D
Ann Dermatol Venereol; 2000 Feb; 127(2):160-5. PubMed ID: 10739973
[TBL] [Abstract][Full Text] [Related]
27. Demographic, behavioural and physician-related determinants of early melanoma detection in a low-incidence population.
Talaganis JA; Biello K; Plaka M; Polydorou D; Papadopoulos O; Trakatelli M; Sotiriadis D; Tsoutsos D; Kechagias G; Gogas H; Antoniou C; Swetter SM; Geller AC; Stratigos AJ
Br J Dermatol; 2014 Oct; 171(4):832-8. PubMed ID: 24749902
[TBL] [Abstract][Full Text] [Related]
28. Skin self-examination in patients at high risk for melanoma: a pilot study.
Phelan DL; Oliveria SA; Christos PJ; Dusza SW; Halpern AC
Oncol Nurs Forum; 2003; 30(6):1029-36. PubMed ID: 14603360
[TBL] [Abstract][Full Text] [Related]
29. Serial screening for melanoma: measures and strategies that have consistently achieved early detection and cure.
Shore RN; Shore P; Monahan NM; Sundeen J
J Drugs Dermatol; 2011 Mar; 10(3):244-52. PubMed ID: 21369639
[TBL] [Abstract][Full Text] [Related]
30. [Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up].
Francken AB; Thompson JF; Bastiaannet E; Hoekstra HJ
Ned Tijdschr Geneeskd; 2008 Mar; 152(10):557-62. PubMed ID: 18402322
[TBL] [Abstract][Full Text] [Related]
31. Routine dermatologist-performed full-body skin examination and early melanoma detection.
Kantor J; Kantor DE
Arch Dermatol; 2009 Aug; 145(8):873-6. PubMed ID: 19687416
[TBL] [Abstract][Full Text] [Related]
32. Presentation and detection of invasive melanoma in a high-risk population.
McPherson M; Elwood M; English DR; Baade PD; Youl PH; Aitken JF
J Am Acad Dermatol; 2006 May; 54(5):783-92. PubMed ID: 16635658
[TBL] [Abstract][Full Text] [Related]
33. Factors influencing participation in cutaneous screening among individuals with a family history of melanoma.
Azzarello LM; Jacobsen PB
J Am Acad Dermatol; 2007 Mar; 56(3):398-406. PubMed ID: 17184873
[TBL] [Abstract][Full Text] [Related]
34. [Investigation of malignant melanoma in an "open house" setting].
Poulsen AG; Larsen FG; Weismann K; Petersen CS; Ravnborg LR; Heidenheim M; Lauritzen TE; Held E; Osterlind AL
Ugeskr Laeger; 1999 Mar; 161(12):1758-61. PubMed ID: 10210976
[TBL] [Abstract][Full Text] [Related]
35. Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in Queensland Australia.
Geller AC; Elwood M; Swetter SM; Brooks DR; Aitken J; Youl PH; Demierre MF; Baade PD
Cancer; 2009 Mar; 115(6):1318-27. PubMed ID: 19189368
[TBL] [Abstract][Full Text] [Related]
36. Who attends skin cancer clinics within a randomized melanoma screening program?
Youl PH; Janda M; Elwood M; Lowe JB; Ring IT; Aitken JF
Cancer Detect Prev; 2006; 30(1):44-51. PubMed ID: 16457967
[TBL] [Abstract][Full Text] [Related]
37. Factors associated with a high tumour thickness in patients with melanoma.
Baumert J; Plewig G; Volkenandt M; Schmid-Wendtner MH
Br J Dermatol; 2007 May; 156(5):938-44. PubMed ID: 17381454
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the usefulness of self-reported risk factors in a skin cancer screening program.
Williams HA; Fritschi L; Beauchamp C; Katris P
Melanoma Res; 2006 Aug; 16(4):341-5. PubMed ID: 16845330
[TBL] [Abstract][Full Text] [Related]
39. Melanoma detection rate and concordance between self-skin examination and clinical evaluation in patients attending a pigmented lesion clinic in Italy.
Carli P; De Giorgi V; Nardini P; Mannone F; Palli D; Giannotti B
Br J Dermatol; 2002 Feb; 146(2):261-6. PubMed ID: 11903237
[TBL] [Abstract][Full Text] [Related]
40. Delay in the diagnosis of cutaneous melanoma: an analysis of 233 patients.
Schmid-Wendtner MH; Baumert J; Stange J; Volkenandt M
Melanoma Res; 2002 Aug; 12(4):389-94. PubMed ID: 12170189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
